Future prospects for regenerated heart using induced pluripotent stem cells

Journal of Pharmacological Sciences

Volumn 125, Issue 1, 2014, Pages 1-5

  Fujita, Jun ^a   Fukuda, Keiichi ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cardiomyocyte; Cell survival; Cell transplantation; Induced pluripotent stem cell; Regenerative medicine

Indexed keywords

ACTIVIN A; BONE MORPHOGENETIC PROTEIN 4; WNT3A PROTEIN;

ARTIFICIAL HEART; CELL CYCLE; CELL DIFFERENTIATION; CELL DIVISION; CELL ENGINEERING; CELL REGENERATION; CELL SCAFFOLDING; CELL SHEET; CELL SURVIVAL; CELL TRANSPLANTATION; CITRIC ACID CYCLE; CLINICAL EFFECTIVENESS; ENDOSCOPIC THERAPY; HEART FAILURE; HEART MUSCLE CELL; HUMAN; PERICARDIAL ENDOSCOPY; PLURIPOTENT STEM CELL; REGENERATIVE MEDICINE; REVIEW; SAFETY;

CELL DIFFERENTIATION; CELL SURVIVAL; CELL- AND TISSUE-BASED THERAPY; HEART FAILURE; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MYOCYTES, CARDIAC; REGENERATIVE MEDICINE; SEVERITY OF ILLNESS INDEX; STEM CELL TRANSPLANTATION;

EID: 84902182234     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.14R01CP     Document Type: Review

References (30)

1. Stehlik J, Edwards LB, Kucheryavaya AY, Benden C, Christie JD, Dobbels F, et al. The registry of the international society for heart and lung transplantation: twenty-eighth adult heart transplant report - 2011. J Heart Lung Transplant. 2011;30: 1078-1094.
2. Strauer B-E, Steinhoff G. 10 years of intracoronary and intramyocardial bone marrow stem cell therapy of the heart: from the methodological origin to clinical practice. J Am Coll Cardiol. 2011;58:1095-1104.
3. Bolli R, Chugh AR, D'Amario D, Loughran JH, Stoddard MF, Ikram S, et al. Cardiac stem cells in patients with ischaemic cardiomyopathy (scipio): initial results of a randomised phase 1 trial. Lancet. 2011;378:1847-1857.
4. Menasché P, Alfieri O, Janssens S, McKenna W, Reichenspurner H, Trinquart L, et al. The myoblast autologous grafting in ischemic cardiomyopathy (magic) trial. Circulation. 2008;117: 1189-1200.
5. Fujita J, Itabashi Y, Seki T, Tohyama S, Tamura Y, Sano M, et al. Myocardial cell sheet therapy and cardiac function. Am J Physiol Heart Circ Physiol. 2012;303:H1169-H1182.
6. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, et al. Embryonic stem cell lines derived from human blastocysts. Science. 1998;282:1145-1147. (Pubitemid 28516247)
7. Gruen L, Grabel L. Concise review: scientific and ethical roadblocks to human embryonic stem cell therapy. Stem Cells. 2006;24:2162-2169. (Pubitemid 44527468)
8. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126:663-676. (Pubitemid 44233629)
9. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007;131:861-872. (Pubitemid 350138099)
10. Nakagawa M, Takizawa N, Narita M, Ichisaka T, Yamanaka S. Promotion of direct reprogramming by transformation-deficient myc. Proc Natl Acad Sci U S A. 2010;107:14152-14157.
11. Seki T, Yuasa S, Oda M, Egashira T, Yae K, Kusumoto D, et al. Generation of induced pluripotent stem cells from human terminally differentiated circulating T cells. Cell Stem Cell. 2010;7:11-14.
12. Mummery CL, Zhang J, Ng ES, Elliott DA, Elefanty AG, Kamp TJ. Differentiation of human embryonic stem cells and induced pluripotent stem cells to cardiomyocytes: a methods overview. Circ Res. 2012;111:344-358.
13. Paige SL, Osugi T, Afanasiev OK, Pabon L, Reinecke H, Murry CE. Endogenous Wnt/beta-catenin signaling is required for cardiac differentiation in human embryonic stem cells. PLoS One. 2010;5:e11134.
14. Kattman SJ, Witty AD, Gagliardi M, Dubois NC, Niapour M, Hotta A, et al. Stage-specific optimization of activin/nodal and bmp signaling promotes cardiac differentiation of mouse and human pluripotent stem cell lines. Cell Stem Cell. 2011; 8:228-240.
15. Willems E, Spiering S, Davidovics H, Lanier M, Xia Z, Dawson M, et al. Small-molecule inhibitors of the Wnt pathway potently promote cardiomyocytes from human embryonic stem cell-derived mesoderm. Circ Res. 2011;109:360-364.
16. Yuasa S, Itabashi Y, Koshimizu U, Tanaka T, Sugimura K, Kinoshita M, et al. Transient inhibition of bmp signaling by noggin induces cardiomyocyte differentiation of mouse embryonic stem cells. Nat Biotech. 2005;23:607-611. (Pubitemid 41724900)
17. Shimoji K, Yuasa S, Onizuka T, Hattori F, Tanaka T, Hara M, et al. G-Csf promotes the proliferation of developing cardiomyocytes in vivo and in derivation from ESCs and IPSCs. Cell Stem Cell. 2010;6:227-37.
18. Wamstad JA, Alexander JM, Truty RM, Shrikumar A, Li F, Eilertson KE, et al. Dynamic and coordinated epigenetic regulation of developmental transitions in the cardiac lineage. Cell. 2012;151:206-220.
19. Tohyama S, Hattori F, Sano M, Hishiki T, Nagahata Y, Matsuura T, et al. Distinct metabolic flow enables large-scale purification of mouse and human pluripotent stem cell-derived cardiomyocytes. Cell Stem Cell. 2013;12:127-137.
20. Hattan N, Kawaguchi H, Ando K, Kuwabara E, Fujita J, Murata M, et al. Purified cardiomyocytes from bone marrow mesenchymal stem cells produce stable intracardiac grafts in mice. Cardiovasc Res. 2005;65:334-344. (Pubitemid 40082475)
21. Hattori F, Chen H, Yamashita H, Tohyama S, Satoh Y-S, Yuasa S, et al. Nongenetic method for purifying stem cell-derived cardiomyocytes. Nat Meth. 2010;7:61-66.
22. Kimura T, Miyoshi S, Okamoto K, Fukumoto K, Tanimoto K, Soejima K, et al. The effectiveness of rigid pericardial endoscopy for minimally invasive minor surgeries: cell transplantation, epicardial pacemaker lead implantation, and epicardial ablation. J Cardiothorac Surg. 2012;7:117.
23. Masumoto H, Matsuo T, Yamamizu K, Uosaki H, Narazaki G, Katayama S, et al. Pluripotent Stem cell-engineered cell sheets re-assembled with defined cardiovascular populations ameliorate reduction in infarct heart function through cardiomyocyte-mediated neovascularization. Stem Cells. 2012;30:1196-1205.
24. Suzuki R, Hattori F, Itabashi Y, Yoshioka M, Yuasa S, Manabe-Kawaguchi H, et al. Omentopexy enhances graft function in myocardial cell sheet transplantation. Biochem Biophys Res Commun. 2009;387:353-359.
25. Rane AA, Christman KL. Biomaterials for the treatment of myocardial infarction a 5-year update. J Am Coll Cardiol. 2011;58:2615-2629.
26. Ott HC, Matthiesen TS, Goh SK, Black LD, Kren SM, Netoff TI, et al. Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart. Nat Med. 2008;14:213-221. (Pubitemid 351214548)
27. Lu TY, Lin B, Kim J, Sullivan M, Tobita K, Salama G, et al. Repopulation of decellularized mouse heart with human induced pluripotent stem cell-derived cardiovascular progenitor cells. Nat Commun. 2013;4:2307.
28. Thompson SA, Burridge PW, Lipke EA, Shamblott M, Zambidis ET, Tung L. Engraftment of human embryonic stem cell derived cardiomyocytes improves conduction in an arrhythmogenic in vitro model. J Mol Cell Cardiol. 2012;53:15-23.
29. Shiba Y, Fernandes S, Zhu WZ, Filice D, Muskheli V, Kim J, et al. Human ES-cell-derived cardiomyocytes electrically couple and suppress arrhythmias in injured hearts. Nature. 2012;489:322-325.
30. Fujita J, Sano M. Treatment of the ventricular tachycardia with engraftment of pluripotent stem cells-derived cardiomyocytes. J Mol Cell Cardiol. 2012;53:3-5.